Organization
Todua Clinic, Tbilisi, Georgia
2 abstracts
Abstract
A phase 2/3 study of fianlimab, cemiplimab, plus chemotherapy versus cemiplimab plus chemotherapy in first-line treatment of advanced non-small cell lung cancer.Org: High Technology Medical Center, University Clinic Ltd., Tbilisi, Georgia, LTD High Technology Hospital Med Center, Batumi, Georgia, JSC Vian Caraps Medline, European University, Tbilisi, Georgia, University of Tennessee Medical Center, Knoxville, TN, Mid Florida Cancer Centers, Orange City, FL,
Abstract
A phase 3 trial of fianlimab (anti–LAG-3) plus cemiplimab (anti–PD-1) versus pembrolizumab in patients with previously untreated unresectable locally advanced or metastatic melanoma.Org: Todua Clinic, Tbilisi, Georgia, High Technology Medical Centre, University Clinic, Tbilisi, Georgia, LTD High Technology Hospital Med Center, Batumi, Georgia, Consilium Medullla, Tbilisi, Georgia, LTD TIM Tbilisi Institute of Medicine, Tbilisi, Georgia,